Annual ROA
-107.49%
-43.15%-67.07%
December 31, 2023
Summary
- As of February 7, 2025, ONCT annual return on assets is -107.49%, with the most recent change of -43.15% (-67.07%) on December 31, 2023.
- During the last 3 years, ONCT annual ROA has fallen by -92.99% (-641.31%).
- ONCT annual ROA is now -528.59% below its all-time high of 25.08%, reached on December 31, 2010.
Performance
ONCT ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-131.30%
-23.05%-21.29%
September 30, 2024
Summary
- As of February 7, 2025, ONCT quarterly return on assets is -131.30%, with the most recent change of -23.05% (-21.29%) on September 30, 2024.
- Over the past year, ONCT quarterly ROA has dropped by -40.26% (-44.22%).
- ONCT quarterly ROA is now -240.47% below its all-time high of 93.47%, reached on June 30, 2016.
Performance
ONCT Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
ONCT ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.1% | -44.2% |
| 3 y3 years | -641.3% | -104.2% |
| 5 y5 years | +12.4% | -104.2% |
ONCT ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -221.1% | at low | -336.2% | at low |
| 5 y | 5-year | -641.3% | +31.6% | -481.8% | +14.5% |
| alltime | all time | -528.6% | +60.2% | -240.5% | +28.9% |
Oncternal Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -131.30%(+21.3%) |
| Jun 2024 | - | -108.25%(+18.9%) |
| Mar 2024 | - | -91.04%(+9.0%) |
| Dec 2023 | -107.49%(+67.1%) | -83.56%(+10.6%) |
| Sep 2023 | - | -75.54%(+11.6%) |
| Jun 2023 | - | -67.71%(+5.3%) |
| Mar 2023 | - | -64.30%(+13.5%) |
| Dec 2022 | -64.34%(+92.2%) | -56.66%(+16.8%) |
| Sep 2022 | - | -48.51%(+11.2%) |
| Jun 2022 | - | -43.61%(+19.8%) |
| Mar 2022 | - | -36.40%(+20.9%) |
| Dec 2021 | -33.48%(+130.9%) | -30.10%(+28.7%) |
| Sep 2021 | - | -23.39%(+3.6%) |
| Jun 2021 | - | -22.57%(-15.7%) |
| Mar 2021 | - | -26.78%(-30.4%) |
| Dec 2020 | -14.50%(-90.8%) | -38.49%(-58.1%) |
| Sep 2020 | - | -91.87%(-0.8%) |
| Jun 2020 | - | -92.60%(-39.7%) |
| Mar 2020 | - | -153.50%(+2.1%) |
| Dec 2019 | -157.23%(+28.2%) | -150.29%(+6.0%) |
| Sep 2019 | - | -141.77%(+2.0%) |
| Jun 2019 | - | -139.04%(+60.9%) |
| Mar 2019 | - | -86.41%(-13.6%) |
| Dec 2018 | -122.66%(+86.3%) | -100.00%(-0.3%) |
| Sep 2018 | - | -100.32%(+11.7%) |
| Jun 2018 | - | -89.82%(-10.7%) |
| Mar 2018 | - | -100.57%(+11.3%) |
| Dec 2017 | -65.83%(-9.0%) | -90.39%(-8.9%) |
| Sep 2017 | - | -99.24%(-31.6%) |
| Jun 2017 | - | -145.13%(+12.9%) |
| Mar 2017 | - | -128.53%(+61.2%) |
| Dec 2016 | -72.34%(+23.9%) | -79.72%(+36.4%) |
| Sep 2016 | - | -58.44%(-162.5%) |
| Jun 2016 | - | 93.47%(-327.5%) |
| Mar 2016 | - | -41.09%(-13.5%) |
| Dec 2015 | -58.39%(-25.0%) | -47.51%(-30.3%) |
| Sep 2015 | - | -68.19%(-63.1%) |
| Jun 2015 | - | -184.57%(+80.8%) |
| Mar 2015 | - | -102.06%(-27.1%) |
| Dec 2014 | -77.81%(-71.2%) | -140.01%(-16.9%) |
| Sep 2014 | - | -168.44%(-0.0%) |
| Jun 2014 | - | -168.49%(+10.9%) |
| Mar 2014 | - | -151.97%(+4.9%) |
| Dec 2013 | -269.86% | -144.85%(+27.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | -113.69%(+90.9%) |
| Jun 2013 | - | -59.57%(+21.8%) |
| Mar 2013 | - | -48.89%(+15.9%) |
| Dec 2012 | -46.86%(+0.6%) | -42.19%(+8.3%) |
| Sep 2012 | - | -38.97%(-31.4%) |
| Jun 2012 | - | -56.77%(+11.4%) |
| Mar 2012 | - | -50.95%(+20.2%) |
| Dec 2011 | -46.60%(-285.8%) | -42.38%(+5.4%) |
| Sep 2011 | - | -40.21%(-22.3%) |
| Jun 2011 | - | -51.75%(-20.9%) |
| Mar 2011 | - | -65.42%(-310.2%) |
| Dec 2010 | 25.08%(-145.0%) | 31.12%(+28.4%) |
| Sep 2010 | - | 24.24%(+85.6%) |
| Jun 2010 | - | 13.06%(-3.2%) |
| Mar 2010 | - | 13.49%(-123.5%) |
| Dec 2009 | -55.79%(+44.3%) | -57.38%(+7.5%) |
| Sep 2009 | - | -53.37%(+16.1%) |
| Jun 2009 | - | -45.97%(+8.4%) |
| Mar 2009 | - | -42.41%(+8.2%) |
| Dec 2008 | -38.67%(+38.5%) | -39.20%(+1.0%) |
| Sep 2008 | - | -38.82%(+2.9%) |
| Jun 2008 | - | -37.72%(+7.7%) |
| Mar 2008 | - | -35.02%(+8.3%) |
| Dec 2007 | -27.93%(-16.6%) | -32.33%(+9.4%) |
| Sep 2007 | - | -29.55%(-8.5%) |
| Jun 2007 | - | -32.31%(-9.6%) |
| Mar 2007 | - | -35.75%(-12.9%) |
| Dec 2006 | -33.49%(-29.1%) | -41.06%(-25.3%) |
| Sep 2006 | - | -55.00%(-4.5%) |
| Jun 2006 | - | -57.59%(+0.4%) |
| Mar 2006 | - | -57.34%(+1.8%) |
| Dec 2005 | -47.26%(+54.5%) | -56.33%(+1.4%) |
| Sep 2005 | - | -55.56%(+28.8%) |
| Jun 2005 | - | -43.12%(+32.1%) |
| Mar 2005 | - | -32.64%(+19.3%) |
| Dec 2004 | -30.58%(-62.7%) | -27.37%(-7.4%) |
| Sep 2004 | - | -29.56%(+3.3%) |
| Jun 2004 | - | -28.62%(-11.4%) |
| Mar 2004 | - | -32.32%(-60.6%) |
| Dec 2003 | -82.00%(-30.7%) | -82.00% |
| Dec 2002 | -118.31%(+48.4%) | - |
| Dec 2001 | -79.70%(-33.1%) | - |
| Dec 2000 | -119.09%(+166.4%) | - |
| Dec 1999 | -44.70% | - |
FAQ
- What is Oncternal Therapeutics annual return on assets?
- What is the all time high annual ROA for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual ROA year-on-year change?
- What is Oncternal Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly ROA year-on-year change?
What is Oncternal Therapeutics annual return on assets?
The current annual ROA of ONCT is -107.49%
What is the all time high annual ROA for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual return on assets is 25.08%
What is Oncternal Therapeutics annual ROA year-on-year change?
Over the past year, ONCT annual return on assets has changed by -43.15% (-67.07%)
What is Oncternal Therapeutics quarterly return on assets?
The current quarterly ROA of ONCT is -131.30%
What is the all time high quarterly ROA for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly return on assets is 93.47%
What is Oncternal Therapeutics quarterly ROA year-on-year change?
Over the past year, ONCT quarterly return on assets has changed by -40.26% (-44.22%)